Dr Waleed Mohammed, Consultant Clinical Oncologist

Dr Waleed Mohammed

Consultant Clinical Oncologist

Book online
|

Dr Waleed Mohammed BA (Cantab), MSc (Oxon), MBBChir (Cantab), MRCP (Lond), FRCR

Consultant Clinical Oncologist

BA (Cantab), MSc (Oxon), MBBChir (Cantab), MRCP (Lond), FRCR

Dr Waleed Mohammed

Consultant Clinical Oncologist BA (Cantab), MSc (Oxon), MBBChir (Cantab), MRCP (Lond), FRCR

Book online
|
BA (Cantab), MSc (Oxon), MBBChir (Cantab), MRCP (Lond), FRCR
HCA-Healthcare-UK

Areas of expertise

  • Brain cancer
  • Brain tumours
  • Lung cancer
  • Radiotherapy
  • Chemotherapy
HCA-Healthcare-UK

Address

About Dr Waleed Mohammed

GMC number: 7080302

Year qualified: 2010

Place of primary qualification: University of Cambridge

Initial consultation fee: £350

Follow up consultation fee: £250

Dr Waleed Mohammed is a Consultant Clinical Oncologist.

Clinical interests include brain cancer, brain tumours and lung cancer.

Procedures offered include radiotherapy, chemotherapy and biological therapy.

Dr Waleed Mohammed's qualifications include BA (Cantab), MSc (Oxon), MBBChir (Cantab), MRCP (Lond), FRCR.

Areas of expertise

  • Adenocarcinoma
  • Astrocytoma
  • Biological therapy
  • Bone metastases
  • Brain cancer
  • Brain metastasis
  • Brain tumours
  • Cancer care
  • Cancer genomics
  • Chemotherapy
  • Chordoma
  • Complementary therapy
  • Craniopharyngiomas
  • Deep inspiration breath hold (DIBH)
  • Ependymoma
  • Gamma knife radiosurgery
  • Genetic testing
  • Genomic testing
  • Glioblastoma
  • Gliomas
  • Haemangioblastoma
  • Image guided radiotherapy (IGRT)
  • Immunotherapy
  • Intensity modulated radiotherapy (IMRT)
  • Lung cancer
  • Magnetic resonance linear accelerator (MR linac)
  • Magnetic resonance linear accelerator-guided stereotactic ablative radiotherapy (MRL-SABR)
  • Medulloblastoma
  • Meningiomas
  • Mesothelioma
  • Metastases
  • Neoadjuvant
  • Non-small cell lung cancer
  • Oligodendroglioma
  • Oligometastic disease
  • Pineal tumours
  • Pituitary tumour
  • Primary lung tumours
  • Radiotherapy
  • RNA/DNA cancer therapy
  • Small cell lung cancer
  • Spinal cord tumour
  • Spinal metastases
  • Squamous cell carcinoma (SCC)
  • Stereotactic ablative radiotherapy (SABR)
  • Stereotactic radiosurgery (SRS)
  • Targeted therapy
  • Thoracic cancers
  • Thymic malignancies
  • Thymus gland cancer
  • Tracheal cancer
  • Volume modulated arc therapy (VMAT)

Professional memberships

General Medical Council